- Roche’s Kadcyla (trastuzumab emtansine) Receives CHMP’s Recommendation for Approval as an Adjuvant Treatment for Patients with HER2+ eBC with Residual Invasive Disease After Neoadjuvant Treatment
Published: Nov 15, 2019 | Tags: Roche, Kadcyla, trastuzumab emtansine, Receives, CHMP, Recommendation, Approval, Adjuvant, Treatment, HER2+ Early Breast Cancer
2. Stanford Medicine Reports Results of Apple Heart Study for Detecting Atrial Fibrillation
Published: Nov 13, 2019 | Tags: Stanford Medicine, Reports, Results, Apple’s Wearable Technology, Detecting, Atrial Fibrillation
3. Sarepta Signs a License Agreement with Stride Bio to Develop In vivo AAV-Based Gene Therapies
Published: Nov 14, 2019 | Tags: Sarepta, Signs, License Agreement, Stride Bio, Develop, In vivo, AAV-Based, Gene Therapies
Published: Nov 14, 2019 | Tags: Shionogi, Fetroja, cefiderocol, Receives, US FDA, Approval, Complicated Urinary Tract Infections
Published: Nov 14, 2019 | Tags: BeiGene, Brukinsa, zanubrutinib, Receives, FDA, Accelerated Approval, Mantle Cell Lymphoma, One Prior Therapy
Published: Nov 14, 2019 | Tags: AstraZeneca, MSD, Report, FDA, Acceptance, NDA, Selumetinib, Patients, Neurofibromatosis Type 1
Published: Nov 14, 2019 | Tags: Allergan, Signs, Exclusive, Option, License Agreement, Exicure, Discover, Develop, SNA-based Therapies, Hair Loss Disorders
Published: Nov 14, 2019 | Tags: Bayer, Collaborates, Dewpoint, Develop, New Therapies, Targeting, Cardiovascular, Gynecological Diseases
Published: Nov 13, 2019 | Tags: Zambon, Signs, License Agreement, Aquestive, Develop, Commercialize, Riluzole Oral Film, Amyotrophic Lateral Sclerosis, EU
Published: Nov 13, 2019 | Tags: Takeda, Expands, Collaboration, Finch Therapeutics, Develop, Microbiome Therapies, Human-First Discovery Platform
Published: Nov 13, 2019 | Tags: Boehringer Ingelheim, Lilly, FDA, EMDAC, Empagliflozin, 2.5mg, Adjunct, Insulin, T1D
12. Pfizer Collaborates with Centogene to Access its Rare Disease Data
Published: Oct 13, 2019 | Tags: Pfizer, Collaborates, CENTOGENE, Access, Rare Disease Data
13. Merck Acquires Calporta Therapeutics for ~$576M
Published: Nov 13, 2019 | Tags: Merck, Acquires, Calporta Therapeutics, ~$576M
14. GSK Reports Results of Nucala (mepolizumab) in P-III Study for Hypereosinophilic Syndrome
Published: Nov 13, 2019 | Tags: GSK, Reports, Results, Nucala, mepolizumab, P-III, Study, Hypereosinophilic Syndrome
Published: Nov 12, 2019 | Tags: Boehringer Ingelheim, Lilly, Commence, P-III, EMPULSE, Jardiance, Acute Heart Failure, Stabilized
Published: Nov 13, 2019 | Tags: AbbVie, Reports, Results, Rinvoq, upadacitinib, P-II/III, SELECT-AXIS 1, Study, Ankylosing Spondylitis
Published: Nov 12, 2019 | Tags: Celgene, Exclusive, Worldwide, License, Agreement, Skyhawk, Therapies, Modulating, RNA Splicing
Published: Nov 12, 2019 | Tags: Celgene, Amends, Existing, Collaboration, Editas, Develop, Commercialize, Autologous Allogeneic T Cell Medicines, Treatment, Cancer, Autoimmune Diseases
19. Mylan and Pfizer Names Viatris as the New Company for Mylan-Upjohn’s Combination
Published: Nov 12, 2019 | Tags: Mylan, Pfizer, Reports, Viatris, New Company Name, Mylan Upjohn Collaboration
Published: Nov 12, 2019 | Tags: Bluebird bio, Forty Seven, Collaborate, Evaluate, All Antibody Conditioning Regimen, Autologous Lentiviral Vector Hematopoietic, Stem Cell Gene Therapy
Published: Nov 11, 2019 | Tags: Janssen, Reports, Results, Tremfya, guselkumab, P-III, DISCOVER, Studies, Active Psoriatic Arthritis
Published: Nov 11, 2019 | Tags: BMS, Reports, Acceptance, sBLA, Opdivo, nivolumab, Yervoy, ipilimumab, Patients, Previously, Treated, Advanced Hepatocellular Carcinoma
23. Lupin to Divest its Stake in Kyowa to Unison for ~$525M
Published: Nov 11, 2019 | Tags: Lupin, Divest, Stake, Kyowa, Unison, ~$525M
Published: Nov 11, 2019 | Tags: Merck, Ervebo, Ebola Zaire Vaccine, rVSVΔG-ZEBOV-GP, live, Receives, EC, Conditional Approval, Prevent, Ebola Virus Disease
Published: Nov 11, 2019 | Tags: Medtronic, Reports, Results, World, Smallest, Pacemaker, MARVEL 2, Study, Patients, Atrioventricular Block
26. Roche Reports Results of Gazyva (obinutuzumab) in P-II NOBILITY Study for Lupus Nephritis
Published: Nov 11, 2019 | Tags: Roche, Reports, Results, Gazyva, obinutuzumab, P-II, NOBILITY Study, Lupus Nephritis
Published: Nov 08, 2019 | Tags: Celgene, Reblozyl, luspatercept–aamt, Receives, FDA, Approval, First Therapy, Treat, Patients, Rare Blood Disorder
Published: Nov 11, 2019 | Tags: Roche, Reports, Results, Risdiplam, Pivotal, SUNFISH, Study, Patients, Type 2 Or 3, Spinal Muscular Atrophy
Published: Nov 08, 2019 | Tags: AstraZeneca, Reports, Pooled, Cardiovascular Safety, Efficacy, Analyses, Roxadustat, P-III, Program, CKD, Anaemia
30. Sandoz to Acquire Aspen’s Japanese Operations and Associated Assets for ~$440M
Published: Nov 11, 2019 | Tags: Sandoz, Aspen, Japanese Operations, Associated, Assets, ~$440M